Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0369004 ANTI-MET IN COMBINATION WITH ANTI-VEGFR2 ANTIBODIES THERAPY FOR CANCER
The present invention provides preparation of medicaments for use in treating and methods of treating cancer selected from the group consisting of gastric...
2016/0369003 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS
Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal...
2016/0369002 MULTISPECIFIC NK ENGAGER PROTEINS
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells...
2016/0369001 NOVEL ANTI-TRANSFERRIN RECEPTOR ANTIBODY THAT PASSES THROUGH BLOOD-BRAIN BARRIER
Disclosed are novel anti transferrin receptor antibody that can pass through the blood-brain barrier, a fusion protein comprising a protein necessary to be...
2016/0369000 4-1BB BINDING MOLECULES
The present disclosure provides isolated binding molecules that bind to human 4-1BB, nucleic acid molecules encoding an amino acid sequence of the binding...
2016/0368999 ANTIBODY FORMULATION
Anti-BAFFR antibodies are formulated as lyophilisate or liquid formulation. The lyophilisates can be reconstituted to give a solution with a high concentration...
2016/0368998 FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB
Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one...
2016/0368997 Antibodies, Uses & Methods
The present invention relates to anti-human OX4OL antibodies, new medical uses and methods.
2016/0368996 METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND ENHANCING TUMOR VACCINES
The present invention provides methods of treating and enhancing efficacy of immunotherapy for a solid tumor in a subject, comprising the step of contacting...
2016/0368995 IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR
Method of treating a subject for a disorder that correlates to increased CXCR8 signaling. The method includes disrupting the activation of receptor CXCR8 by...
2016/0368994 ANTI-CLL-1 ANTIBODIES AND METHODS OF USE
The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g.,...
2016/0368993 ALPHA-V BETA-6 INTEGRIN-BINDING ANTIBODY FRAGMENTS
The present invention provides isolated, engineered multivalent antibody fragments that specifically bind .alpha..sub.V.beta..sub.6 integrin. In particular...
2016/0368992 A METHOD OF INCREASING GIPCR SIGNALIZATION IN THE CELLS OF A SCOLIOTIC SUBJECT
There is provided a method of increasing GIPCR signalization in the cells of a subject in need thereof comprising administering to the subject an effective...
2016/0368991 SOLUBLE MIC NEUTRALIZING MONOCLONAL ANTIBODY FOR TREATING CANCER
Disclosed are compositions and methods relating to antibodies that bind soluble Major Histocompatibility Complex class I chain-related (sMIC). Specifically,...
2016/0368990 ANTI B7-H3 ANTIBODY
The present invention relates to an antibody having a therapeutic effect on a tumor. That is, the invention relates to an antibody which binds to B7-H3 to...
2016/0368989 ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
The instant disclosure provides antibodies that specifically bind to human CTLA-4 and antagonize CTLA-4 function. Also provided are pharmaceutical compositions...
2016/0368988 HUMAN CD3 BINDING ANTIBODY
The invention is among others concerned with human CD3 binding antibodies comprising a heavy chain and light chain wherein said heavy chain comprises a...
2016/0368987 BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DISEASES
The present invention relates to bispecific constructs that specifically bind to cytotoxic T cells and, simultaneously, to IL5R-carrying target cells, as well...
2016/0368986 Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
Disclosed are methods and compositions of anti-B cell antibodies, preferably anti-CD22 antibodies, for diagnosis, prognosis and therapy of B-cell associated...
2016/0368985 HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g.,...
2016/0368984 Compositions Comprising Antibodies to Lingo or Fragments Thereof
Endogenous LINGO-1 is a negative regulator for neuronal survival, axon regeneration, oligodendrocyte differentiation and myelination. Molecules that block...
2016/0368983 COMPOSITIONS AND METHODS FOR TREATING OBESITY
The present invention provides anti-ghrelin antibodies or antigen-binding molecules that are capable of sequestering ghrelin and inhibiting ghrelin-mediated...
2016/0368982 Treatment of Dermatological Pathologies
Skin inflammation in a human subject is reduced by administering to the subject a pharmaceutical composition that includes a pharmaceutically acceptable...
2016/0368981 HUMAN ANTI-IL-32 ANTIBODIES
Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and...
2016/0368980 INHIBITION OF GRANULOCYTE COLONY STIMULATING FACTOR IN THE TREATMENT OF CANCER
The present invention relates to the discovery that granulocyte colony stimulating factor (G-CSF) as well as granulocyte colony stimulating factor receptor...
2016/0368979 ANTI EOTAXIN-2 ANTIBODIES THAT RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES
Provided are isolated polyspecific antibodies directed to a unique epitope in the chemokine eotaxin 2. The antibodies bind additional CCR3-binding chemokines....
2016/0368978 AMINO ACID SEQUENCES DIRECTED AGAINST THE ANGIOPOIETIN/TIE SYSTEM AND POLYPEPTIDES COMPRISING THE SAME FOR THE...
The present invention relates to amino acid sequences that are directed against proteins from the group of the Angiopoietin/Tie family such as Tie1, Tie2,...
2016/0368977 HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE
The present application relates to humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide, and to the use of said antibodies in...
2016/0368976 ANTIBODIES TO KALLIDIN AND DES-ARG9-KALLIDIN
The invention provides antibodies that specifically bind to Kallidin or des-Arg10-Kallidin. The invention also provides pharmaceutical compositions, as well as...
2016/0368975 METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA
Methods and compositions for the treatment of .beta.-thalassemia are provided. Methods and compositions restore or increase erythrocyte maturation in...
2016/0368974 IMMUNOGLOBULIN-LIKE MOLECULES DIRECTED AGAINST FIBRONECTIN-EDA
The present invention is concerned with immunoglobulin (Ig)-like molecules or fragments thereof for use in treatment, prevention, or prevention of progression...
2016/0368973 ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
The present invention provides anti-C1q antibodies and methods of using the same.
2016/0368972 Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein
Methods, compositions and kits are provided for treating a subject exposed to or at risk for exposure to a disease agent using a pharmaceutical composition...
2016/0368971 IGA MULTI-SPECIFIC BINDING MOLECULES
The present invention concerns IgA multi-specific binding molecules. In particular, the invention concerns multi-specific, including bispecific, binding...
2016/0368970 PROCESS
The invention relates to a modified process for the purification of IgG, improving the yield of IgG per liter of starting material without compromising the...
2016/0368969 NOVEL POLYVALENT IMMUNOTHERAPEUTICS OF HIGH SPECIFICITY BASED ON MODIFIED ANTIBODIES AND A LYOPHILIZED...
The invention is related to the production and development of a lyophilized injectable formulation of modified antibodies or their variants, highly specific...
2016/0368968 METHOD FOR OBTAINING THIN FIBRIL COLLAGEN BY CONTACTING NATIVE COLLAGEN WITH AN ANTIBODY
A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril...
2016/0368967 METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRPV4
TRPV4 activation increases vascular permeability and can be triggered by both chemical and mechanical cues. This activation of TRPV4 can contribute to a number...
2016/0368966 NOVEL a4B7 PEPTIDE DIMER ANTAGONISTS
The invention relates to disulfide-rich dimer molecules which inhibit binding of .alpha.4.beta.7 to the mucosal addressin cell adhesion molecule (MAdCAM) in...
2016/0368965 Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for...
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2016/0368964 TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF
A trifunctional molecule comprising a target-specific ligand, a ligand that binds a protein associated with the TCR complex and a T cell receptor signaling...
2016/0368963 TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
The invention provides a novel family of biologically active neuropeptides and the nucleic aid molecules coding for same. The peptides are derived for the...
2016/0368962 Melanocortin Receptor Ligands
The present invention is directed to compounds according to formula, (R.sup.2R.sup.3)-A.sup.1-c(A.sup.2-A.sup.3-A.sup.4-A.sup.5-A.sup.6-A.sup- ...
2016/0368961 Glycosylated Polypeptide and Drug Composition Containing said Polypeptide
[Problem] To provide a glycosylated polypeptide having affinity to somatostatin receptors and, compared to somatostatins, having improved in-blood stability....
2016/0368960 GLUCAGON AND GLP-1 CO-AGONIST COMPOUNDS
The present invention provides glucagon and GLP-1 co-agonist compounds that are useful in the treatment of type 2 diabetes, obesity, nonalcoholic fatty liver...
2016/0368959 SURFACE-BINDING PEPTIDE
The embodiments relate to surface-binding peptides having the capability of binding to surfaces of biocompatible materials and can thereby be used to...
2016/0368958 HJURP PEPTIDES AND VACCINES INCLUDING THE SAME
Isolated peptides derived from SEQ ID NO: 50 and fragments thereof that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable...
2016/0368957 IL-17 Binding Compounds and Medical Uses Thereof
The present invention relates to new IL-17 inhibiting polypeptides, corresponding fusion proteins, compositions and medical uses thereof.
2016/0368956 METHOD OF PREVENTIVELY TREATING A SUBJECT AT THE RISK OF DEVELOPING INFECTIONS OF A RESPIRATORY VIRUS
A method of preventively treating a subject at the risk of developing infections of a respiratory virus is disclosed. The method includes a step of...
2016/0368955 COMPOUND, USE, ANTI-TUMOR PHARMACEUTICAL COMPOSITION,GENE CONSTRCT FOR POLYPEPTIDE EXPRESSION, PROCESS FOR THE...
The use of HspBP1 protein or part thereof for the preparation of an anti-tumor pharmaceutical composition, and its optional combination with one or more...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.